2019
DOI: 10.1002/adsc.201801694
|View full text |Cite
|
Sign up to set email alerts
|

Copper‐Catalyzed Oxidative C(sp3)−H/N−H Cross‐Coupling of Hydrocarbons with P(O)−NH Compounds: the Accelerating Effect Induced by Carboxylic Acid Coproduct

Abstract: An chelation-assisted oxidative C (sp 3 )À H/NÀ H cross coupling of hydrocarbons with P(O)À NH compounds using copper acetate as catalyst is described. The results of kinetic experiments, mechanistic studies and DFT calculations demonstrate the importance of acetic acid coproduct as an additive for promoting the formation of intermediate bis((diphenylphosphoryl)(quinolin-8yl)amino)copper (6), and consequently accelerating the construction of C(sp 3 )À N bond. The reaction proceeded efficiently with a wide arra… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
1
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
2

Relationship

1
1

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 87 publications
0
1
0
Order By: Relevance
“…Therefore, recent progress in this field has been demonstrated by new synthetic strategies, such as Staudinger-type reactions of organic azides with phosphite esters 7 and transition metal-catalyzed aromatic and benzylic C–H phosphoramidations. 8 Despite the significant advances made in this field, current C–H phosphoramidation protocols remain limited to aryl and benzyl substrates. Meanwhile, direct modification of complex natural products and pharmaceuticals to incorporate phosphoramidates remains challenging.…”
mentioning
confidence: 99%
“…Therefore, recent progress in this field has been demonstrated by new synthetic strategies, such as Staudinger-type reactions of organic azides with phosphite esters 7 and transition metal-catalyzed aromatic and benzylic C–H phosphoramidations. 8 Despite the significant advances made in this field, current C–H phosphoramidation protocols remain limited to aryl and benzyl substrates. Meanwhile, direct modification of complex natural products and pharmaceuticals to incorporate phosphoramidates remains challenging.…”
mentioning
confidence: 99%